Evaluation of the Impact of the Use of NewSpringForMe on Transplanted Patients ' Quality of Life and Support

Conditions: Hematologic Diseases; Bone Marrow Transplantation; Hematopoietic Stem Cell Transplantation Interventions: Device: NewSpringForMe digital solution Sponsors: Fonds de Dotation HTC Project; Saint-Louis Hospital, Paris, France; Nutricia Nutrition Clinique; Clinicprosport; ELLYE; Association A ïda; Gilead Sciences; Pfizer; Groupe Apicil; Association Laurette Fugain; Fondation du LEEM; Fondation AFNIC; Pierre Fabre Medicament; Novartis Pharmaceuticals; University Hospital, Clermont-Ferrand; LAPSCO, Université Clermont-Auvergne Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials